{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:41:01Z","timestamp":1774568461288,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T00:00:00Z","timestamp":1555286400000},"content-version":"vor","delay-in-days":683,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Portuguesa de Cardiologia"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.repc.2016.11.009","type":"journal-article","created":{"date-parts":[[2017,6,9]],"date-time":"2017-06-09T10:15:54Z","timestamp":1497003354000},"page":"465-472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Mid-regional pro-adrenomedullin and ST2 in heart failure: Contributions to diagnosis and prognosis"],"prefix":"10.1016","volume":"36","author":[{"given":"Daniela","family":"Lopes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz","family":"Menezes Falc\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.repc.2016.11.009_bib0290","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2016.11.009_bib0295","first-page":"1","article-title":"Heart failure","volume":"1","author":"Braunwald","year":"2013","journal-title":"JACC: Heart Fail"},{"key":"10.1016\/j.repc.2016.11.009_bib0300","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s12265-013-9465-0","article-title":"Heart failure biomarkers","volume":"6","author":"Choudhary","year":"2013","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.repc.2016.11.009_bib0305","first-page":"147","article-title":"Cardiac biomarkers: new tools for heart failure management","volume":"2","author":"Iqbal","year":"2012","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.repc.2016.11.009_bib0310","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMoa020233","article-title":"Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure","volume":"347","author":"Maisel","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2016.11.009_bib0315","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.amjcard.2004.12.032","article-title":"The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study","volume":"95","author":"Januzzi","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.repc.2016.11.009_bib0320","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/eurheartj\/ehi631","article-title":"NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study","volume":"27","author":"Januzzi","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2016.11.009_bib0325","doi-asserted-by":"crossref","first-page":"h910","DOI":"10.1136\/bmj.h910","article-title":"The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting","volume":"350","author":"Roberts","year":"2015","journal-title":"Br Med J"},{"key":"10.1016\/j.repc.2016.11.009_bib0330","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.jacc.2007.02.037","article-title":"Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure","volume":"49","author":"Fonarow","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2016.11.009_bib0335","doi-asserted-by":"crossref","first-page":"R116","DOI":"10.1186\/cc9067","article-title":"In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED Study","volume":"14","author":"Di Somma","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.repc.2016.11.009_bib0340","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1001\/archinte.166.3.315","article-title":"Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department","volume":"166","author":"Januzzi","year":"2006","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.repc.2016.11.009_bib0345","first-page":"52","article-title":"Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data","author":"Masson","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.repc.2016.11.009_bib0350","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1253\/circj.CJ-10-0368","article-title":"Biological variation of brain natriuretic peptide and cardiac events in stable outpatients with nonischemic chronic heart failure","volume":"75","author":"Nishiyama","year":"2011","journal-title":"Circ J"},{"key":"10.1016\/j.repc.2016.11.009_bib0355","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/eurheartj\/eht463","article-title":"Natriuretic peptide-guided heart failure management","volume":"35","author":"Troughton","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2016.11.009_bib0360","doi-asserted-by":"crossref","first-page":"e58287","DOI":"10.1371\/journal.pone.0058287","article-title":"Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2686 patients in 12 randomized trials","volume":"8","author":"Savarese","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.repc.2016.11.009_bib0365","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehu090","article-title":"Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis","author":"Troughton","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2016.11.009_bib0370","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1016\/j.bbadis.2012.12.014","article-title":"Biomarkers and diagnostics in heart failure","volume":"1832","author":"Gaggin","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.repc.2016.11.009_bib0375","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0024-3205(99)00358-6","article-title":"Adrenomedullin: potential in physiology and pathophysiology","volume":"66","author":"Jougasaki","year":"2000","journal-title":"Life Sci"},{"key":"10.1016\/j.repc.2016.11.009_bib0380","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11897-012-0096-6","article-title":"Mid-regional pro-adrenomedullin in acute heart failure: a better biomarker or just another biomarker","volume":"9","author":"Potocki","year":"2012","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.repc.2016.11.009_bib0385","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1161\/01.CIR.0000118466.47982.CC","article-title":"Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis and renal damage","volume":"109","author":"Niu","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2016.11.009_bib0390","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11897-016-0292-x","article-title":"Neprilysin and natriuretic peptide regulation in heart failure","volume":"13","author":"Bayes-Genis","year":"2016","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.repc.2016.11.009_bib0395","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ejhf.250","article-title":"Neprilysin inhibition to treat heart failure: a tale of science, serendipity, and second chances","volume":"17","author":"McMurray","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.repc.2016.11.009_bib0400","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1136\/hrt.2009.170696","article-title":"Evaluation of novel biomarkers for the diagnosis of acute destabilized heart failure in patients with shortness of breath","volume":"95","author":"Dieplinger","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.repc.2016.11.009_bib0405","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/eurheartj\/ehs136","article-title":"Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnea","volume":"33","author":"Shah","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2016.11.009_bib0410","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.jacc.2010.02.025","article-title":"Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial","volume":"55","author":"Maisel","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2016.11.009_bib0415","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1553-2712.2011.01150.x","article-title":"Short-term mortality risk in emergency department acute heart failure","volume":"18","author":"Peacock","year":"2011","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.repc.2016.11.009_bib0420","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ajem.2013.12.045","article-title":"Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERifying DYspnea trial","volume":"32","author":"Travaglino","year":"2014","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.repc.2016.11.009_bib0425","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/eurjhf\/hfq031","article-title":"Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure","volume":"12","author":"Von Haehling","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.repc.2016.11.009_bib0430","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/eurjhf\/hfp206","article-title":"The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial","volume":"12","author":"Masson","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.repc.2016.11.009_bib0435","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/eurjhf\/hft116","article-title":"Mid-region pro-adrenomedullin adds predictive value to clinical predictors and Framingham risk score for long-term mortality in stable outpatients with heart failure","author":"Xue","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.repc.2016.11.009_bib0440","doi-asserted-by":"crossref","DOI":"10.1016\/S0735-1097(01)01269-4","article-title":"Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction","volume":"37","author":"Richards","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2016.11.009_bib0445","doi-asserted-by":"crossref","first-page":"3B","DOI":"10.1016\/j.amjcard.2015.01.034","article-title":"The biology of ST2: the International ST2 Consensus Panel","volume":"115","author":"Pascual-Figal","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.repc.2016.11.009_bib0450","article-title":"Soluble ST2 in heart failure","author":"Dieplinger","year":"2014","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.repc.2016.11.009_bib0455","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jacc.2007.05.014","article-title":"Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study","volume":"50","author":"Januzzi","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2016.11.009_bib0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1875318301205010001","article-title":"Soluble ST2 as a diagnostic and prognostic marker for acute heart failure syndromes","volume":"5","author":"Henry-Okafor","year":"2012","journal-title":"Open Biomark J"},{"key":"10.1016\/j.repc.2016.11.009_bib0465","doi-asserted-by":"crossref","first-page":"32B","DOI":"10.1016\/j.amjcard.2015.01.038","article-title":"Serial ST2 testing in hospitalized patients with acute heart failure","volume":"115","author":"Maisel","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.repc.2016.11.009_bib0470","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.jacc.2008.07.042","article-title":"Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure","volume":"52","author":"Rehman","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2016.11.009_bib0475","doi-asserted-by":"crossref","DOI":"10.1007\/s00392-015-0811-x","article-title":"Prognostic value of sST2 added to BNP in acute heart failure with preserved or reduced ejection fraction","author":"Fri\u00f5es","year":"2015","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.repc.2016.11.009_bib0480","doi-asserted-by":"crossref","first-page":"26B","DOI":"10.1016\/j.amjcard.2015.01.037","article-title":"ST2 and prognosis in acutely decompensated heart failure: the International ST2 Consensus Panel","volume":"115","author":"Januzzi","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.repc.2016.11.009_bib0485","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0300-8932(10)70249-9","article-title":"Soluble ST2 monitoring provides additional risk stratification for outpatients with decompensated heart failure","volume":"63","author":"Bayes-Genis","year":"2010","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.repc.2016.11.009_bib0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.cardfail.2013.11.003","article-title":"Heart failure therapy-induced early ST2 changes may offer long-term therapy guidance","volume":"19","author":"Breidthardt","year":"2013","journal-title":"J Card Fail"},{"key":"10.1016\/j.repc.2016.11.009_bib0495","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ahj.2013.02.029","article-title":"Biological variation of galectin-3 and soluble ST2 for chronic heart failure: implication on interpretation of test results","volume":"165","author":"Wu","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.repc.2016.11.009_bib0500","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.cardfail.2013.09.005","article-title":"Soluble ST2 serum concentration and renal function in heart failure","volume":"19","author":"Bayes-Genis","year":"2013","journal-title":"J Card Fail"},{"key":"10.1016\/j.repc.2016.11.009_bib0505","first-page":"311","article-title":"Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea","volume":"2","author":"Shah","year":"2009","journal-title":"Circ: Heart Fail"},{"key":"10.1016\/j.repc.2016.11.009_bib0510","doi-asserted-by":"crossref","first-page":"64B","DOI":"10.1016\/j.amjcard.2015.01.043","article-title":"ST2 and patient prognosis in chronic heart failure","volume":"115","author":"Bayes-Genis","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.repc.2016.11.009_bib0515","first-page":"180","article-title":"High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure","volume":"4","author":"Ky","year":"2011","journal-title":"Circ: Heart Fail"},{"key":"10.1016\/j.repc.2016.11.009_bib0520","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/eurjhf\/hfr156","article-title":"Combined use of high-sensitivity ST2 and NT-proBNP to improve the prediction of death in heart failure","volume":"14","author":"Bayes-Genis","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.repc.2016.11.009_bib0525","first-page":"418","article-title":"Prognostic value of soluble ST2 in the Valsartan Heart Failure trial","volume":"7","author":"Anand","year":"2014","journal-title":"Circ: Heart Fail"},{"key":"10.1016\/j.repc.2016.11.009_bib0530","first-page":"65","article-title":"Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure","volume":"2","author":"Gaggin","year":"2014","journal-title":"JACC: Heart Fail"},{"key":"10.1016\/j.repc.2016.11.009_bib0535","doi-asserted-by":"crossref","first-page":"70B","DOI":"10.1016\/j.amjcard.2015.01.044","article-title":"ST2 testing for chronic heart failure therapy monitoring: the International ST2 Consensus Panel","volume":"115","author":"Januzzi","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.repc.2016.11.009_bib0540","first-page":"1206","article-title":"Soluble concentrations of the interleukin receptor family member ST2 and \u03b2-blocker therapy in chronic heart failure","volume":"6","author":"Gaggin","year":"2013","journal-title":"Circ: Heart Fail"},{"key":"10.1016\/j.repc.2016.11.009_bib0545","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.amjcard.2014.05.062","article-title":"Effect of spironolactone on 30-day death and heart failure rehospitalization (from the COACH study)","volume":"114","author":"Maisel","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.repc.2016.11.009_bib0550","first-page":"477","article-title":"Charting a roadmap for heart failure biomarker studies","volume":"2","author":"Ahmad","year":"2014","journal-title":"JACC: Heart Fail"},{"key":"10.1016\/j.repc.2016.11.009_bib0555","first-page":"183","article-title":"Multiple biomarkers for risk prediction in chronic heart failure","volume":"5","author":"Ky","year":"2012","journal-title":"Circ: Heart Fail"},{"key":"10.1016\/j.repc.2016.11.009_bib0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2013.01.228","article-title":"Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study","author":"Lassus","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.repc.2016.11.009_bib0565","first-page":"1172","article-title":"Soluble ST2 in ambulatory patients with heart failure: association with functional capacity and long-term outcomes","volume":"6","author":"Felker","year":"2013","journal-title":"Circ: Heart Fail"},{"key":"10.1016\/j.repc.2016.11.009_bib0570","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2217\/fca.14.36","article-title":"Using ST2 in cardiovascular patients: a review","volume":"10","author":"Daniels","year":"2014","journal-title":"Future Cardiol"}],"container-title":["Revista Portuguesa de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255116302323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255116302323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:05:00Z","timestamp":1760108700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0870255116302323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0870255116302323"],"URL":"https:\/\/doi.org\/10.1016\/j.repc.2016.11.009","relation":{},"ISSN":["0870-2551"],"issn-type":[{"value":"0870-2551","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mid-regional pro-adrenomedullin and ST2 in heart failure: Contributions to diagnosis and prognosis","name":"articletitle","label":"Article Title"},{"value":"Revista Portuguesa de Cardiologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repc.2016.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}